I now have solid, multi-source information to give a thorough answer. Here it is:
Why Vitamin A is Given with Vaccines (especially Measles)
There are two distinct contexts where vitamin A and vaccines go together:
1. Vitamin A as TREATMENT during active Measles
The core reason: Low vitamin A levels are directly linked to increased measles morbidity and mortality. Vitamin A is needed for optimal effector T-cell function and resolution of measles infection.
The WHO recommends giving all children with acute measles vitamin A once daily for 2 days:
| Age | Dose |
|---|
| < 6 months | 50,000 IU/day × 2 days |
| 6-11 months | 100,000 IU/day × 2 days |
| ≥ 12 months | 200,000 IU/day × 2 days |
Source: Dermatology 2-Volume Set 5e, Treatment of Measles
This is because measles virus itself causes immunosuppression and depletes vitamin A stores, and children who are already deficient (common in developing countries) fare much worse - with case fatality rates up to 20-30%.
2. Vitamin A as PROPHYLAXIS co-administered with vaccine visits (India's National Programme)
India's national immunization program deliberately links vitamin A supplementation doses to vaccine contact points - to ensure coverage and reduce missed opportunities:
| Timing | Dose | Given With |
|---|
| 9 months | 100,000 IU | Measles vaccine |
| 16-18 months | 200,000 IU | DPT Booster |
| 24 months | 200,000 IU | Routine visit |
| 30 months | 200,000 IU | Routine visit |
| 36 months | 200,000 IU | Routine visit |
Source: Park's Textbook of Preventive and Social Medicine, Prophylactic Vitamin A
This co-administration at 9 months is practical: it piggybacks on an existing contact point (measles vaccine visit) to ensure vitamin A reaches children when they are at highest risk for deficiency - and the measles vaccine visit is the first one after 6 months of age.
3. The Immunological Link
Vitamin A deficiency impairs:
- Effector T-cell function - weakening cell-mediated immunity that controls measles
- Epithelial integrity - making respiratory and GI mucosa more vulnerable to infection
- Antibody responses - reducing vaccine-induced protection in malnourished children
A 2025 systematic review (PMID
40787612) confirmed that micronutrient supplementation including vitamin A enhances vaccine responses in undernourished children, and a 2026 systematic review on measles management (PMID
41638401) reaffirmed vitamin A as a first-line treatment in acute measles.
In summary: Vitamin A is given with the measles vaccine visit because (1) the visit is a contact point to deliver prophylactic vitamin A to at-risk children, (2) measles infection depletes vitamin A and worsens disease in deficient children, and (3) adequate vitamin A is needed for both optimal immune function and effective vaccine response.